Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Kymera Therapeutics, Inc.”

29 pharma patents match "Kymera Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 29
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 29 pharmaceutical patents matching "Kymera Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

29 results for “Kymera Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11485743

    Protein degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted

  2. US 11352350

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  3. US 11318205

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  4. US 11117889

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  5. US 10874743

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.